PMID- 32903481 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200928 IS - 1664-042X (Print) IS - 1664-042X (Electronic) IS - 1664-042X (Linking) VI - 11 DP - 2020 TI - Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells on the Acute Cigarette Smoke-Induced Pulmonary Inflammation Model. PG - 962 LID - 10.3389/fphys.2020.00962 [doi] LID - 962 AB - Cigarette smoke (CS) has been reported to induce oxidative stress and inflammatory process in the lungs. However, the role of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) in the regulation of pulmonary inflammation remains unclear. The objective of this study is to investigate the effects of hUC-MSCs on lung inflammation in the acute CS-induced pulmonary inflammation animal model. Eight-week-old male C57BL/6 mice were intravenously administered 3 x 10(6), 1 x 10(7), and 3 x 10(7) cells/kg of hUC-MSCs as well as normal saline alone (control) after 3 days of CS exposure. Mice exposed to high-efficiency particulate air (HEPA)-filtered room air served as the CS control group. High-dose (3 x 10(7) cells/kg) hUC-MSC administration significantly decreased tumor necrosis factor (TNF)-alpha in the bronchoalveolar lavage fluid (BALF) of CS-exposed mice (p < 0.05). The chemokine (CXC motif) ligand 1/keratinocyte chemoattractant (CXCL1/KC) in BALF were significantly reduced by low-dose (3 x 10(6) cells/kg) and high-dose (3 x 10(7) cells/kg) hUC-MSC (p < 0.05). Medium-dose hUC-MSC administration decreased interleukin (IL)-1beta in lung of mice, and TNF-alpha and caspase-3 were decreased in the lung of CS-exposed mice by medium- and high-dose MSC (p < 0.05). Low-dose hUC-MSCs significantly elevated serum CXCL1/KC and IL-1beta in CS-exposed mice (p < 0.05). Our results suggest that high-dose hUC-MSCs reduced pulmonary inflammation and had antiapoptotic effects in acute pulmonary inflammation. CI - Copyright (c) 2020 Chen, Chen, Lin, Chien, Chen, Wen, Hsiao and Chuang. FAU - Chen, Xiao-Yue AU - Chen XY AD - School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan. FAU - Chen, Yi-Ying AU - Chen YY AD - School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan. FAU - Lin, Willie AU - Lin W AD - Meridigen Biotech Co. Ltd., Taipei, Taiwan. FAU - Chien, Chia-Wen AU - Chien CW AD - Meridigen Biotech Co. Ltd., Taipei, Taiwan. FAU - Chen, Chien-Han AU - Chen CH AD - Meridigen Biotech Co. Ltd., Taipei, Taiwan. FAU - Wen, Yu-Chieh AU - Wen YC AD - Meridigen Biotech Co. Ltd., Taipei, Taiwan. FAU - Hsiao, Ta-Chih AU - Hsiao TC AD - Graduate Institute of Environmental Engineering, National Taiwan University, Taipei, Taiwan. FAU - Chuang, Hsiao-Chi AU - Chuang HC AD - School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan. AD - Cell Physiology and Molecular Image Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. AD - Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan. LA - eng PT - Journal Article DEP - 20200812 PL - Switzerland TA - Front Physiol JT - Frontiers in physiology JID - 101549006 PMC - PMC7434987 OTO - NOTNLM OT - cigarette smoke OT - inflammation OT - lung OT - mesenchymal stem cells OT - oxidative stress EDAT- 2020/09/10 06:00 MHDA- 2020/09/10 06:01 PMCR- 2020/08/12 CRDT- 2020/09/09 17:54 PHST- 2020/05/14 00:00 [received] PHST- 2020/07/15 00:00 [accepted] PHST- 2020/09/09 17:54 [entrez] PHST- 2020/09/10 06:00 [pubmed] PHST- 2020/09/10 06:01 [medline] PHST- 2020/08/12 00:00 [pmc-release] AID - 10.3389/fphys.2020.00962 [doi] PST - epublish SO - Front Physiol. 2020 Aug 12;11:962. doi: 10.3389/fphys.2020.00962. eCollection 2020.